# Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

> **NCT02746185** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 159 (actual)

## Conditions studied

- Neoplasm
- Venous Thromboembolism

## Interventions

- **DRUG:** rivaroxaban
- **DRUG:** Low-molecular-weight heparin

## Key facts

- **NCT ID:** NCT02746185
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-04-25
- **Final completion:** 2018-04-25
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2018-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02746185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02746185, "Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02746185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*